These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 10230181)

  • 61. Editorial: Time for a New Conversation on Stimulant Use.
    Charach A
    J Am Acad Child Adolesc Psychiatry; 2020 Aug; 59(8):929-930. PubMed ID: 31634569
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Practice parameter for the use of stimulant medications.
    Ravenel SD
    J Am Acad Child Adolesc Psychiatry; 2002 Oct; 41(10):1146-7; author reply 1147. PubMed ID: 12364835
    [No Abstract]   [Full Text] [Related]  

  • 63. Stimulants and Pediatric Cardiovascular Risk.
    Zito JM; Burcu M
    J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):538-545. PubMed ID: 27258470
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of CNS Stimulants for Attention-Deficit/Hyperactivity Disorder on Growth: Epidemiology and Approaches to Management in Children and Adolescents.
    Baweja R; Hale DE; Waxmonsky JG
    CNS Drugs; 2021 Aug; 35(8):839-859. PubMed ID: 34297331
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Considerations in the Use of Stimulants in Sport.
    Reardon CL; Factor RM
    Sports Med; 2016 May; 46(5):611-7. PubMed ID: 26712509
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society, and the Canadian Academy of Child and Adolescent Psychiatry.
    Warren AE; Hamilton RM; Bélanger SA; Gray C; Gow RM; Sanatani S; Côté JM; Lougheed J; LeBlanc J; Martin S; Miles B; Mitchell C; Gorman DA; Weiss M; Schachar R
    Can J Cardiol; 2009 Nov; 25(11):625-30. PubMed ID: 19898693
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Stimulant Treatment and Potential Adverse Outcomes in Pediatric Populations With Bipolar Disorder: A Systematic Review of the Literature.
    O'Connor H; Hutt Vater C; DiSalvo M; Faraone SV; Wozniak J
    J Atten Disord; 2024 Mar; 28(5):740-750. PubMed ID: 38156605
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Growth Trajectories in Stimulant-Treated Children Ages 6 to 12: An Electronic Medical Record Analysis.
    Biederman J; DiSalvo M; Green A; Hutt Vater C; Driscoll H; Faraone SV
    J Dev Behav Pediatr; 2023 Feb-Mar 01; 44(2):e80-e87. PubMed ID: 36750982
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adverse effects of stimulant medications in children and adolescents: focus on drug abuse.
    Greydanus DE; Cates KW; Sadigh N
    Int J Adolesc Med Health; 2019 Sep; 31(4):. PubMed ID: 31483757
    [No Abstract]   [Full Text] [Related]  

  • 70. Stimulant Drugs and Stimulant Use Disorder.
    Song W; Simona A; Zhang P; Bates DW; Urman RD
    Anesthesiol Clin; 2024 Mar; 42(1):103-115. PubMed ID: 38278583
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Stimulant medications and growth.
    Poulton A; Nanan R
    J Am Acad Child Adolesc Psychiatry; 2009 May; 48(5):574-576. PubMed ID: 19395905
    [No Abstract]   [Full Text] [Related]  

  • 72. Adverse effects of stimulant medications in children and adolescents: focus on cardiovascular issues.
    Greydanus DE; Cates KW; Sadigh N
    Int J Adolesc Med Health; 2019 Aug; 31(3):. PubMed ID: 31553697
    [No Abstract]   [Full Text] [Related]  

  • 73. Stimulant intolerance in children with Angelman syndrome with hyperactivity: a case series.
    Keary CJ; Thom RP; McDougle CJ
    Psychiatr Genet; 2022 Apr; 32(2):80-86. PubMed ID: 35348128
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Adverse effects of stimulant medications in children and adolescents: focus on sleep and growth disturbances.
    Greydanus DE; Cates KW; Sadigh N
    Int J Adolesc Med Health; 2019 May; 31(2):. PubMed ID: 31079090
    [No Abstract]   [Full Text] [Related]  

  • 75. Premarket safety and efficacy studies for ADHD medications in children.
    Bourgeois FT; Kim JM; Mandl KD
    PLoS One; 2014; 9(7):e102249. PubMed ID: 25007171
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inappropriate uses of stimulant medications.
    Volkmar FR; Hoder EL; Cohen DJ
    Clin Pediatr (Phila); 1985 Mar; 24(3):127-30. PubMed ID: 2578911
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Safety of stimulant medications for attention deficit hyperactivity disorder in paediatric congenital heart disease.
    Chung LM; Hariharan G; Varma S
    J Paediatr Child Health; 2023 Mar; 59(3):580-588. PubMed ID: 36789801
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Stimulant Therapy Utilization for Neurocognitive Deficits in Mild Traumatic Brain Injury.
    Coris EE; Moran B; Sneed K; Del Rossi G; Bindas B; Mehta S; Narducci D
    Sports Health; 2022; 14(4):538-548. PubMed ID: 34292098
    [TBL] [Abstract][Full Text] [Related]  

  • 79. ADHD Medication in the Longer Term.
    Taylor E
    Z Kinder Jugendpsychiatr Psychother; 2019 Nov; 47(6):542-546. PubMed ID: 31012801
    [No Abstract]   [Full Text] [Related]  

  • 80. A chart review of cyproheptadine for stimulant-induced weight loss.
    Daviss WB; Scott J
    J Child Adolesc Psychopharmacol; 2004; 14(1):65-73. PubMed ID: 15142393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.